Glempiris Inc is categorized under Health Information and Referral Programs in Orlando, FL .
Glempiris Inc was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Information and Referral Programs business, which does work in the B2C market, and is classified as a Health Information and Referral Programs, under code number 6219991 by the NAICS.
If you are seeking more information, feel free to contact Catherine Saitoti, Marketing at the company’s single location by writing to 3956 West Town Center Boulevard # 313, Orlando, Florida FL 32837 or by phoning (407) 705-2695. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Glempiris Inc |
Contact Person: | Catherine Saitoti, Marketing |
Address: | 3956 West Town Center Boulevard # 313, Orlando, Florida 32837 |
Phone Number: | (407) 705-2695 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Information and Referral Programs |
SIC Code: | 8099 |
NAICS Code: | 6219991 |
Share This Business: |
Glempiris Inc was started in 0 to provide professional Health Information and Referral Programs under the SIC code 8099 and NAICS code 6219991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Catherine Saitoti, Marketing for inquiries that concern Glempiris Inc by calling the company number (407) 705-2695, as your correspondence is most welcome. Additionally, the physical location of the single location of Glempiris Inc can be found at the coordinates 28.36612,-81.42078 as well as the street address 3956 West Town Center Boulevard # 313 in Orlando, Florida 32837.
For its online presence, you may visit Glempiris Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.